BioCentury
ARTICLE | Company News

Argonex Inc, Rohm and Haas Co. deal

August 16, 1999 7:00 AM UTC

The companies formed a joint venture, RHeoGene LLC (Charlottesville), to develop Rohm and Haas's ligand induced gene expression technology for mammalian gene therapy applications. Rohm and Haas will o...